Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
4 June 2026
No Comments
Phase I study of an AI-designed oral formulation sets a new standard in drug
Tag: Quotient Sciences
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
4 March 2026
No Comments
Philadelphia, PA – 26 February 2026 – Quotient Sciences, a leading integrated CRDMO (Contract Research, Development